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Serum levels of Interleukin-6 (IL-6), a proinflammatory
cytokine, are increased in early stages of inflammatory
diseases such as infection and sepsis. Assay systems
which permit its measurement within a few hours and
as a single measurement have not been reported so
far. We therefore evaluated a now commercially avail-
able automated method for IL-6 measurement on the
Cobas Core® immunological analyzer (Roche Diagnos-
tic Systems) which enables single IL-6 measurement
within about 1 hour. The automated assay correlates
well with an established, manual microtiter plate as-
say (Biosource GmbH) which uses the same antibodies
and reagents (r=0.98). Accuracy of the automated
method was established by adding known amounts of
IL-6 international reference preparation. Recovery of
the international standard was in the range of 92–
104 %. The automated assay had a precision of single-
tons below 6 % and was linear up to 2800 pg/ml. This
automated assay provides a suitable, convenient and
time saving method for measurement of IL-6 serum
levels in the routine clinical laboratory. 
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Introduction
Interleukin-6 (IL-6) is a pleiotropic cytokine with a wide
range of biological functions. It is implicated in the in-
duction of fever, acute phase response, activation of B
and T lymphocytes and stimulation of hematopoesis.
During inflammation IL-6 is produced and released into
the circulation in response to bacterial toxins and other
cytokines by cells such as monocytes and endothelial
cells. Bacterial, viral and protozoan infection have been
reported to elevate serum IL-6 levels (1–3). Clinical
studies in neutropenic patients indicate that IL-6 levels
are elevated within 2–3 days before clinical manifesta-
tions of inflammatory processes are evident (4). Serum
levels of IL-6 are raised earlier in the clinical course
than well recognized diagnostic markers of infection
such as C-reactive protein (5). High concentrations of
serum IL-6 have been reported in patients with bacte-
rial infection, in contrast to those without infection on
admission to the intensive care unit (6). Furthermore,
IL-6 levels are a sensitive parameter for early diagnosis
of neonatal infection and outcome in septic patients (2,
7–9). 
Although these studies suggest that serum levels of
IL-6 may have important diagnostic value, no suitable
methods have been reported so far which permit meas-
urement of this cytokine within a few hours to utilize it as
a clinical parameter in critically ill patients. In the present
study we evaluated an automated immunoassay for IL-6
measurement using a coated bead enzyme-linked im-
munosorbant assay (ELISA) kit (Biosource GmbH, Rat-
ingen, Germany) run on a Cobas Core® immunological
analyzer (Roche Diagnostic Systems, Basel, Switzer-
land) which offers the possibility of measuring IL-6 in a
random access mode. Automated IL-6 measurement on
the Cobas Core® was compared with the manual
method measured on microtiter plates (formerly sup-
plied by Medgenix GmbH, Ratingen, Germany) which
uses the same antibodies and reagents (7–9). 
Materials and Methods
Reagents
Coated bead ELISA kits and microtiter plate ELISA kits were
supplied by Biosource GmbH (Ratingen, Germany). Both kits
use monoclonal antibodies raised against distinct epitopes of
recombinant IL-6. Detection antibody was labeled with horse-
radish peroxidase and tetramethylbenzidine was used as
chromogenic substrate. The microtiter plate assay recognizes
recombinant and natural glycosylated IL-6 without interfer-
ence from IL-6 soluble receptors sIL-6R and sgp130. For ana-
lytical recovery studies IL-6 standard from NIBSC (The Na-
tional Institute for Biological Standards and Control, NIBSC
Blanche Lane, South Mimms, Potters Bar, Herfordshire EN6
3QG, England) was employed. The vial (preparation 89/548),
which contains 1 µg recombinant IL-6 and has the assigned po-
tency of 100 000 IU, was reconstituted with 1 ml distilled water
as recommended by the supplier (10). Serum without measur-
able IL-6 was used for further dilution.
Patients and blood samples
Residual sera from blood samples routinely submitted to the
Institute of Clinical Chemistry for analysis of clinical chemical
parameters from the medical intensive care unit (n=177) were
kept frozen at –70 °C until analysis. Sera from critically ill pa-
tients with high levels of IL-6 were pooled and aliquoted for
linearity, stability and precision analysis. For comparison
blood was collected from 30 healthy volunteers, centrifuged
and kept frozen at –70 °C until analysis. 
Instrumentation and assay procedure
The assay was performed on a Roche Diagnostic System Co-
bas Core® immunological analyzer. The program parameters
were set as outlined in Table 1. Capture antibody coated beads
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and detection antibody were added simultaneously and incu-
bated for 30 minutes. After the addition of chromogenic re-
agent and incubation for 15 minutes, measurements were
performed photometrically at a wavelength of 450 nm. Six
standards containing 0, 35, 442, 853, 1749 and 2815 pg/ml of
recombinant IL-6 were used for calibration. IL-6 measure-
ments on microtiter plates were performed with the enzyme-
linked immunosorbent assay (ELISA, Biosource GmbH Rat-
ingen, Germany) as recommended by the supplier.
Measurements with the Cobas Core® were performed singly,
while all measurements with microtiter plates were per-
formed in duplicate.
Statistics
Descriptive data are given as mean ± standard deviation. The
reproducibility of the test was evaluated by measurement of
recombinant, lyophilized controls and pooled patient sera re-
peatedly on the same day (intra-assay variation) or on differ-
ent days (inter-assay variation). Linearity was determined
with serum from patients with high levels of IL-6 which was di-
luted with serum without detectable IL-6 and also with the
highest standard containing 2815 pg/ml recombinant IL-6. Lin-
ear regression analysis was performed and Pearson´s rank
correlation coefficient determined for linearity analysis. For
method comparison Passing-Bablok regression was per-
formed and Kendall´s Tau coefficient was determined (11).
Results
Calibration curve and linearity
A typical standard curve obtained by Cobas Core® (A)
and the microtiter plate assay (B) is shown in Figure 1.
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Tab. 1 Program parameters of Cobas Core® used for IL-6 determination.
General Std. 4 853.0
Test name IL-6 Std. 5 1749.0
Kit size 100 Std. 6 2815.0
Reaction mode 1-step Standard replicate Duplicate
Calibration mode Lin Interpol Kit control Off
Decimal position 1
Std/CS-K unit (Kit) pg/ml Calculation
Sample/CS Unit (Lab) pg/ml Replicate Dev:
Unit factor 1.0000 Std. 1 No
Std. 2 No
Analytical Conversion factor 1.0000
Replicate sample/CS Single Offset 0.0000
Immuno reaction 1 time 30 min Test range:
Volume of Low Std. 1 Nominal pg/ml
CS/Sample 200 µl High Std. 2 Nominal pg/ml
Standard 200 µl Abnormal limit low No pg/ml
Reagent 1 100 µl Warning limit low No pg/ml
Dilution factor Undil Warning limit high No pg/ml
Factor 1 No Abnormal limit high No pg/ml
Factor 2 No
Factor 3 No Assign
Default Dilution Undil Beads            B Label 1
Reagent 1      G 2
Calibration Std 1              H1 3A
Calibration interval mode On Request Std 2              H2 3B
No. of Standards 6 Std 3             H3 3C
Nominal conc: Std 4              H4 3D
Std. 1 0.0 Std 5              H5 3E
Std. 2 35.0 Std 6              H6 3F
Std. 3 442.0
Fig. 1 Typical standard curves for the automated assay (A)
and the ELISA on microtiter plate (B). 
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Absorbance response to IL-6 concentration measured
using the Cobas Core® assay is expressed by the equa-
tion 
A450 = 0.95057 [IL-6]Cobas Core® + 0.00291 and 
r2 = 0.99982. 
Dilution of the highest recombinant standard with
serum without detectable IL-6 showed a linear re-
sponse up to 2815 pg/ml IL-6. In addition, sera of 4 pa-
tients with various IL-6 levels were diluted 1:2, 1:4 and
1:8 with serum without detectable IL-6. Recovery
ranged between 102 and 117 % indicating a good line-
arity throughout the calibration range.
Precision
Recombinant lyophilized controls K1 and K2 contain-
ing 124 and 286 pg/ml IL-6 and four pools P1, P2, P3 
and P4 were used for precision analysis. Mean IL-6 
levels of these pools were P1=2.0±0.2, P2=128.9±5.5,
P3=267.6±11.7 and P4=1070±24.4 pg/ml, respectively.
Within-run CV´s for the lyophilized controls K1 and K2
with the automated method were 3.0 and 4.4 % (n=10),
and the between-run CV´s were 5.5 and 4.1 %, (each
n=25), respectively. Measurement of the four pools re-
vealed within-run CV´s of 14.4 (n=10), 3.6 (n=10), 5.3
(n=10), and 2.3 (n=8) % and between-run CV´s of 10.9
(n=10), 4.3 (n=25), 4.1 (n=25), and 2.3 (n=10) %, respec-
tively. 
Accuracy
Figure 2 shows the results of a dilution experiment of
the NIBSC reference material (2500 pg/ml) with a serum
sample without detectable IL-6. The regression line
over the whole measuring range was defined by the
equation 
IL-6 [Cobas Core®]=1.012[NIBSC standard] – 21.9. 
The correlation coefficient was r=0.9987. The recovery
of the IL-6 standard was between 92.5 and 102.4 %. In
addition 3 sera with various IL-6 levels were spiked
with three different concentrations of NIBSC standard
(250, 500 and 1000 pg/ml). The recovery of IL-6, which
varied between 90 and 109 % (Tab. 2), indicates accu-
rate measurement of IL-6 with the automated assays. 
Stability
Twenty samples were kept at 4 °C for 24 hours and
showed no significant decrease of serum IL-6. In addi-
tion 27 samples were measured immediately after col-
lecting them and then frozen for 72 hours at –18 °C. No
significant loss of activity could be observed after
thawing. 
Method comparison
For comparison with the microtiter plate assay serum
samples of 130 patients with IL-6 levels up to 1000
pg/ml from the intensive care unit were measured with
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Tab. 2 Spiking recovery of recombinant IL-6 standard (-
NIBSC) in sera of patients with various IL-6 concentrations.
Sample Spiking Expected Observed Recovery 
amount (%)
1 – – 1070
250 1317 1346 102
875 1879 1882 100
1750 2636 2441 93
2 – – 522
250 770 837 109
875 1350 1423 105
1750 2123 1914 90
3 – – 264
250 513 559 109
875 1100 1172 106
1750 1946 1930 99
4 – – <1.5
250 249 235 94
875 847 831 98
1750 1637 1669 102
Fig. 2 Dilution recovery of 2500 pg/ml IL-6 (NIBSC, prepara-
tion 89/548). Dilution was performed with serum of a healthy
control without detectable IL-6.
Fig. 3 Correlation between measurements of IL-6 (pg/ml)
performed with the ELISA on microtiter plate and the auto-
mated assay on Cobas Core®.
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Cobas Core® and microtiter plate. The regression equa-
tion was defined by 
IL-6CobasCore = 0.92 IL-6microtiterplate + 5.32 pg/ml 
and t = 0.9062 
(Fig. 3). 
Detection limit
Detection limit, which is defined as the mean IL-6 value
of 20 repeat measurements of zero standard plus 2
standard deviation was 1.5 pg/ml. 
Values of healthy controls
In sera from 20 out of 30 healthy controls, IL-6 levels
were below the detection limit of 1.5 pg/ml. The 10 re-
maining controls had IL-6 levels between 1.7 and 8.4 pg/
ml. Mean IL-6 levels of all healthy controls were 2.1±1.8
pg/ml.
Discussion
We here report for the first time an analytical evalua-
tion of an automated IL-6 assay. Measurements of IL-6
performed routinely on microtiter plates have sug-
gested that this cytokine may be a suitable early labor-
atory parameter during inflammatory processes. Reli-
able and quick measurement of IL-6 levels may be
useful in diagnostic and therapeutic decisions. How-
ever, for this purpose its serum level must be available
daily and within a few hours. Measurement of IL-6 on
microtiter plates is time consuming and expensive
when run in small series and therefore usually not
available on the same day. The automated method
evaluated in this study requires about 1 hour, which of-
fers the possibility for measurement of IL-6 in a random
access mode. Together with the operating characteris-
tics of Cobas Core (throughput of 150 samples per
hour, good user friendlyness), which has been investi-
gated in detail (12,13), automated measurement of IL-6
can be recommended for routine laboratories.
Although using single determinations, the impreci-
sion of the automated method was in general below 
6 %. In the lowest concentration pool, which was close
to the detection limit, a CV up to 14.4 % was found. This
may still be acceptable. In contrast to the microtiter
plate assay, this precision allows a single measurement
saving time and sample volume. In the present study,
the automated assay on the Cobas Core® was linear up
to concentrations of 2815 pg/ml. In contrast, in the mi-
crotiter plate ELISA, the absorbance response was lin-
ear up to only about 400 pg/ml. The correlation coeffi-
cient between the manual and the automated assay
was r2= 0.8745 up to concentrations of 400 pg/ml and 
r2= 0.6751 for values above 400 pg/ml. Linearity over a
wide range of standards permits the use of the auto-
mated assay for serum samples with IL-6 levels over
1000 pg/ml without any dilution step. This may be of im-
portance since high levels in the range between 1000
and 2000 pg/ml are often encounted in severe inflam-
matory conditions such as sepsis and septic shock (3). 
Most data on cytokines reported in the literature are
difficult to compare because of great variations in the
values. However, calibration with the international
standard (NIBSC 89/548) may improve comparisons of
various assays (14). With serial dilutions of the NIBSC
standard we obtained a close correlation of measured
values. This is in good agreement with previous stud-
ies showing a good correlation of the Medgenix micro-
titer plate ELISA assay, which uses the same antibodies
and reagents, with the NIBSC standard (15). For this
reason results obtained with the assay reported here
are comparable with the Medgenix assay and probably
also with other IL-6 assays, which are calibrated
against the NIBSC standard.
One critical factor for routine analysis is the instabil-
ity of analytes in serum samples (16). We did not find
any significant changes in IL-6 values when sera were
stored at 4 °C for 24 hours or at –30 °C for several days.
We did not test the stability at different temperatures or
longer storage periods. 
In summary, the automated IL-6 assay on Cobas
Core® correlates well with the manual microtiter plate
method and this finding justifies its use in the routine
laboratory. Further clinical studies are necessary to
clarify whether IL-6 measurement in a random access
mode may be a useful tool as an early marker of inflam-
mation and therapy control.
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